Frederic Hilke

exceet Card AG designs, develops, and manufactures advanced technologies and systems solutions in the areas of information technology security, payment systems, and Near Field Communication (NFC). Its smart card products offer data verification, personalization, and mailing services. The core markets served are health, access, banking and financial transactions, corporate security, and government. The company was founded in 1924 and is headquartered in Unterschleissheim, Germany.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

exceet Card Group AG operates as a holding company with interest in manufacturing identification chip cards. It offers innovative smart card technologies and solutions in banking, health, events, loyalty and public services to the customers. The firm also provides personalisation, mailing/lettershop, text administration, and reporting services. The company was founded on December 8, 2000 and is headquartered in Paderborn, Germany.

Part of Wilh. Werhahn KG, HUMAN Gesellschaft für Biochemica und Diagnostica mbH is a healthcare company based in Wiesbaden, Germany. HUMAN has been serving the healthcare sector for 50 years with high-quality products, renowned services, and individualized support. With R&D and production anchored in and with partners in more than 160 countries, HUMAN is regarded as a player in the IVD industry. The German company's worldwide network of subsidiaries and distributors guarantees being close to the users, providing service and support. HUMAN offers a constant supply of products and support, and its customers' satisfaction is its success. The company was founded in 1972. Ralph Neuberger has been the CEO of the company since 2002.

ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland.

INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany.

DIO Deutsche Immobilien Opportunitäten AG is a German real estate investment company founded in 2013 by Moritz Kraneis and Philipp Kraneis. The private company is based in Frankfurt, Germany. The company invests in commercial real estate with unique development potential, focusing on properties with optimization potential in economically strong regional locations. The company aims for maximum diversification by investing in various real estate types and locations.

Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022.

SPK Süddeutsche Privatkapital AG is a private company based in Heidelberg, Germany. The German company provides investment services.

Nordic SSW 1000 Verwaltungs AG is an investment holding German company. The private company is based in Hamburg, Germany.

NeraCare GmbH operates clinics. The company is based in Cologne, Germany. The German company was founded by Daniel von Janowski and Friedrich Ackermann. Daniel von Janowski has been the CEO since incorporation.

Indical Topco AB is a Swedish company that owns and manages shares, as well as real and movable properties. The private company is based in Stockholm, Sweden.

Avelo AG is a Swiss company that aims to save lives by providing fast and actionable infectious disease diagnosis closer to the patient. Avelo is based in Schlieren, CH. The company's solution is a breath collection device that works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia. The company was founded in 2020 by Melanie Aregger and Tobias Broger, with Melanie Aregger serving as the CEO since 2020.